Acacetin shows potency against SARS-CoV-2 spike protein
Researchers use molecular docking to screen phytocompounds and evaluate their binding affinity with SARS-CoV-2.
Source: news-medical.net
Page 17 - Binding Affinity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Binding Affinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Binding Affinity Today - Breaking & Trending Today
In silico screening of natural ACE2 inhibitors
Researchers identify potential ACE2 inhibitors through a virtual screening protocol.
Source: news-medical.net
How will mutations change the SARS-CoV-2 spike protein in the future?
A new Cells review discusses the factors that affect the function of the SARS-CoV-2 S protein and provides theoretical limits of this viral protein.
Source: news-medical.net
Identification of a rapid test for SARS-CoV-2 neutralization via antibodies and nanobodies
Researchers presented a technique called rapid in vitro inhibition assay (RIVIA), whereby potential SARS-CoV-2 antibody and nanobody candidates can be rapidly screened.
Source: news-medical.net
Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice
Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.
Source: news-medical.net